AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
AtriCure (Nasdaq: ATRC), a company specializing in surgical treatments for atrial fibrillation, left atrial appendage management, and post-operative pain management, has announced its participation in the Piper Sandler 36th Annual Healthcare Conference. The company's management will engage in a fireside discussion on Wednesday, December 4, 2024, at 9:00 am EST. The presentation will be accessible via live audio webcast through the Investors section of AtriCure's website.
AtriCure (Nasdaq: ATRC), un'azienda specializzata nei trattamenti chirurgici per fibrillazione atriale, gestione dell'appendice atriale sinistra e gestione del dolore post-operatorio, ha annunciato la sua partecipazione alla 36ª Conferenza Annuale sulla Salute di Piper Sandler. Il management dell'azienda parteciperà a una discussione informale mercoledì 4 dicembre 2024, alle 9:00 am EST. La presentazione sarà disponibile tramite webcast audio in diretta nella sezione Investitori del sito web di AtriCure.
AtriCure (Nasdaq: ATRC), una empresa especializada en tratamientos quirúrgicos para fibrilación auricular, gestión de la appendice auricular izquierda y manejo del dolor postoperatorio, ha anunciado su participación en la 36ª Conferencia Anual de Salud de Piper Sandler. La dirección de la empresa participará en una discusión informal el miércoles 4 de diciembre de 2024, a las 9:00 am EST. La presentación estará disponible a través de una transmisión de audio en vivo a través de la sección para Inversores del sitio web de AtriCure.
AtriCure (Nasdaq: ATRC)는 심방세동, 왼쪽 심방 부속기 관리 및 수술 후 통증 관리에 대한 외과적 치료를 전문으로 하는 회사로, Piper Sandler 제36회 연례 의료 회의에 참가한다고 발표했습니다. 회사 관리팀은 2024년 12월 4일 수요일 오전 9시(EST)에 화상 토론에 참여할 예정입니다. 프레젠테이션은 AtriCure 웹사이트의 투자자 섹션을 통해 실시간 오디오 웹캐스트로 제공됩니다.
AtriCure (Nasdaq: ATRC), une entreprise spécialisée dans les traitements chirurgicaux pour la fibrillation auriculaire, la gestion de l'appendice auriculaire gauche et la gestion de la douleur postopératoire, a annoncé sa participation à la 36e Conférence Annuelle de Santé Piper Sandler. La direction de l'entreprise participera à une discussion informelle le mercredi 4 décembre 2024 à 9h00 EST. La présentation sera accessible via un webdiffusion audio en direct dans la section Investisseurs du site Web d'AtriCure.
AtriCure (Nasdaq: ATRC), ein Unternehmen, das sich auf chirurgische Behandlungen von Vorhofflimmern, das Management des linken Vorhofohres und das Management postoperativer Schmerzen spezialisiert hat, hat seine Teilnahme an der 36. jährlichen Gesundheitskonferenz von Piper Sandler angekündigt. Das Management des Unternehmens wird am Mittwoch, dem 4. Dezember 2024, um 9:00 Uhr EST an einer informellen Diskussion teilnehmen. Die Präsentation wird über einen Live-Audio-Webcast im Bereich Investoren auf der Website von AtriCure zugänglich sein.
- None.
- None.
AtriCure’s management is scheduled to participate in a fireside discussion on Wednesday, December 4, 2024, at 9:00 am Eastern Standard Time. Interested parties may access a live audio webcast of the presentation by visiting the “Investors” section of the company’s website at https://ir.atricure.com
About AtriCure
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists, cardiothoracic and thoracic surgeons around the globe use AtriCure technologies for the treatment of Afib, reduction of Afib related complications and post-operative pain management. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE® probes are cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on X (formerly Twitter) @AtriCure.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241120781972/en/
Angie Wirick
AtriCure, Inc.
Chief Financial Officer
(513) 755-5334
awirick@atricure.com
Marissa Bych
Gilmartin Group
Investor Relations
marissa@gilmartinir.com
Source: AtriCure, Inc.
FAQ
When is AtriCure (ATRC) presenting at the Piper Sandler Healthcare Conference 2024?
How can investors watch AtriCure's (ATRC) Piper Sandler Conference presentation?
What type of presentation will AtriCure (ATRC) give at the Piper Sandler Conference?
What medical conditions does AtriCure (ATRC) focus on treating?
